Early Gestational Diabetes Raises Postpartum Diabetes Risk, finds study
Researchers have discovered in a new study that women diagnosed with gestational diabetes mellitus (GDM) earlier than 24 weeks of pregnancy, termed early GDM, are almost twice as prone to developing diabetes mellitus (DM) post-delivery as those diagnosed with later pregnancy. The findings demonstrate that early GDM not only has a greater risk of postpartum diabetes but also is linked to more cases of impaired glucose tolerance following delivery. The study was published in the Journal of Diabetes and Its Complications by Sarah J. and fellow researchers.
GDM is usually screened for at or after 24 weeks' gestation, but increased early diagnosis has been more frequent as prenatal care remains more proactive. But whether early detection was linked to poorer outcomes postpartum has been subject to ongoing research until now.
The research was a systematic review and meta-analysis of the evidence. Researchers reviewed PubMed, EMBASE, WHO International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials from inception until March 2023. Researchers included observational studies and randomized controlled trials that contrasted the postpartum rate of DM among women diagnosed with early GDM (earlier than 24 weeks) compared to women with standard GDM (diagnosed at or later than 24 weeks).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.